Welcome to our dedicated page for Definitive Healthcare news (Ticker: DH), a resource for investors and traders seeking the latest updates and insights on Definitive Healthcare stock.
Definitive Healthcare Corp. (NASDAQ: DH) is a data and analytics company focused on healthcare commercial intelligence, and its news flow reflects this role in the U.S. healthcare market. The company regularly issues press releases detailing quarterly financial results, business performance and guidance, giving investors and analysts insight into trends in its subscription-based platform and related metrics.
News about Definitive Healthcare often includes earnings announcements for its fiscal quarters, where it discusses revenue, net loss or income, non-GAAP measures such as Adjusted EBITDA and Adjusted Net Income, and cash flow metrics. These releases also highlight customer wins across end markets like medical device companies, digital health organizations, healthcare revenue cycle management firms, regional health systems, healthcare-focused private equity firms and healthcare advertising agencies.
Another important category of news involves corporate developments and leadership updates. The company reports inducement equity awards to senior leaders, changes in executive roles, and board-level updates, such as director resignations and committee appointments. These items provide context on how Definitive Healthcare structures its leadership and aligns compensation with its growth plans.
Definitive Healthcare also announces its participation in investor conferences and the timing of its quarterly financial results conference calls and webcasts. These updates indicate when management will discuss financial performance and outlook with the investment community.
By following the DH news feed, readers can monitor the company’s financial disclosures, leadership and governance changes, customer and market highlights, and investor relations events in one place. This page can be a useful reference for tracking how Definitive Healthcare communicates its progress and priorities over time.
Definitive Healthcare (Nasdaq: DH) has launched Passport Express, integrating analytical data from Analytical Wizards with extensive therapy-specific data. This new product enhances biopharma pre-launch planning across 20 therapy areas, providing vital commercial intelligence to accelerate market performance.
Passport Express offers ready-to-use analytics with up to seven interactive dashboards focused on market and brand dynamics, treatment pathways, and patient compliance. The aim is to simplify data sourcing for biopharma companies, ensuring up-to-date information is readily accessible.
Definitive Healthcare Corp. (Nasdaq: DH) will release its second quarter financial results for the period ending June 30, 2022, on August 4, 2022, after market close. A conference call will be held at 5:00 PM ET to discuss these results, which can be accessed via a live audio webcast on the company's Investor Relations website. A replay of the call will be available until August 18, 2022. Definitive Healthcare is known for transforming data into healthcare commercial intelligence, helping clients navigate market opportunities.
Definitive Healthcare (Nasdaq: DH) has launched Monocl ExpertInsight 2.0 and its mobile app Monocl ExpertGO, revolutionizing expert identification in healthcare. This platform grants medical affairs teams access to nearly 13 million expert profiles globally, enhancing productivity and streamlining workflows. Key features include live filters, advanced search options, and KOL mapping. Brazilian healthcare data has also been added to the platform. Existing customers can access these tools at no extra cost, aimed at accelerating drug and device market readiness.
Definitive Healthcare Corp. (Nasdaq: DH) will present at the Stifel 2022 Cross Sector Insight Conference. The session is scheduled for June 7, 2022, at 1:15 p.m. Eastern Time, featuring CEO Jason Krantz, CFO Rick Booth, and President Robert Musslewhite. Interested parties can access a live webcast on Definitive Healthcare's investor relations website, with a replay available for a limited time. Definitive Healthcare specializes in healthcare commercial intelligence, using data and analytics to help clients succeed in the healthcare market.
Summary not available.
Definitive Healthcare Corp. (Nasdaq: DH) announced that CEO Jason Krantz and CFO Rick Booth will present at the J.P. Morgan 50th Annual Global Technology, Media and Communications Conference. The presentation is scheduled for May 23, 2022, at 9:20 a.m. Eastern Time. A live webcast will be accessible through their investor relations website, with a replay available for a limited time. Definitive Healthcare specializes in healthcare commercial intelligence, providing clients insights to drive success in the healthcare market.
Definitive Healthcare Corp. (Nasdaq: DH) reported a 36% year-over-year increase in first-quarter revenue, reaching $50.1 million compared to $36.9 million in Q1 2021. Despite a net loss of ($13.1) million, which is 26% of revenue, the company showed strong operational cash flow at $13.6 million, or 27% of revenue. Adjusted net income rose to $7.7 million, highlighting profitability amidst growth. Looking ahead, the company forecasts Q2 2022 revenue between $53.0 - $54.0 million, indicating continued momentum.
Definitive Healthcare Corp. (Nasdaq: DH) announced the appointment of Robert Musslewhite as the new CEO, effective August 1, 2022. Founder Jason Krantz will transition to Executive Chairman but will remain involved in the company's strategic direction. Musslewhite, previously President, has a strong SaaS and healthcare background, including experience as CEO at OptumInsight and The Advisory Board Company. He aims to leverage his expertise to further advance the company's growth. Definitive Healthcare emphasizes its commitment to healthcare commercial intelligence with nearly 3,000 customers.
Definitive Healthcare Corp. (Nasdaq: DH) announced that it will release its first quarter financial results for the period ending March 31, 2022, on May 5, 2022, after market close. A conference call and webcast will be held at 4:30 PM ET to discuss these results. Interested parties can access the audio webcast on Definitive Healthcare's Investor Relations website. A replay of the call will be available until May 19, 2022, using the provided dial-in numbers.
Definitive Healthcare (Nasdaq: DH) has launched the Passport Analytics Suite, designed to enhance the efficiency of life sciences organizations in product development and commercialization. Powered by technologies from the recently acquired Analytical Wizards, the suite includes Passport Promotional Analytics and Passport Planning & Performance. These tools enable clients to optimize brand performance, marketing strategies, and product planning by integrating diverse data sources. This innovation positions Definitive Healthcare as a leader in offering comprehensive, data-agnostic analytics solutions.